15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Lucid Diagnostics Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. The target range is very wide, $2.00 to $9.50 (about 4.8x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $4.25 sits 374% above the current $0.90. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $-0.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Lucid Diagnostics Inc.
As of Sep, 4 of 4 firms rate LUCD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LUCD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.06 – $-0.05 · 3 analysts · -47% YoY
Next period, 3 analysts expect Lucid Diagnostics Inc to earn $-0.05 a share (range $-0.06 – $-0.05), versus $-0.10 a year earlier. Full-year consensus is $-0.24, growing to $-0.17 the year after.
REVENUE · NEXT QUARTER
$2.0M
Range $1.5M – $2.5M · 3 analysts · +30% YoY
Revenue is expected to reach $2.0M (range $1.5M – $2.5M), +29.8% year-over-year. Full-year consensus is $6.3M, rising to $16.7M next year.
Top analysts covering Lucid Diagnostics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LUCD.
#1
Ross Osborn
Cantor Fitzgerald · Rank #166
Buy
$3.00+234.4% to target
Overall win rate
33%
+ Follow
#2
Mike Matson
Needham · Rank #210
Buy
$3.00+234.4% to target
Overall win rate
34%
+ Follow
#3
KM
Kyle Mikson
Canaccord Genuity · Rank #263
Buy
$3.00+234.4% to target
Overall win rate
34%
+ Follow
#4
Anthony Vendetti
Maxim Group · Rank #335
Buy
$2.00+122.9% to target
Overall win rate
30%
+ Follow
#5
Edward Woo
Ascendiant Capital · Rank #430
Buy
$9.50+959.0% to target
Overall win rate
26%
+ Follow
LUCD stock forecast FAQ
What is LUCD's average 12-month price target?+
The 4 analysts with a live target average $4.25 for Lucid Diagnostics Inc over the next 12 months, ranging from a $9.50 high to a $2.00 low.
Is LUCD stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LUCD?+
The Street-high target is $9.50 (Ascendiant Capital), and the Street-low is $2.00 (Maxim Group). The average of all 4 active targets is $4.25.
How many Wall Street analysts cover LUCD?+
4 analysts have an active rating on Lucid Diagnostics Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering LUCD?+
Among analysts who currently cover LUCD, Ross Osborn of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #166). Their current call is Buy with a $3.00 target.
What is Lucid Diagnostics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.06 – $-0.05) across 3 analysts. Full-year EPS is projected at $-0.24, rising to $-0.17 the following year.
How much revenue is Lucid Diagnostics Inc expected to report next quarter?+
Consensus revenue is $2.0M (range $1.5M – $2.5M). Full-year revenue is projected at $6.3M, growing to $16.7M next year.
Have analysts been upgrading or downgrading LUCD lately?+
As of Sep, 4 of 4 firms rate LUCD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LUCD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
